The following questions were also discussed and put in order of priority at the workshop:

By what methods can a health care professional safely and effectively wean a person with fibromyalgia off a medication?

How prevalent is polypharmacy (or simultaneous use of multiple medications to treat a single condition) in fibromyalgia patients and are lower doses of more drugs better than high doses of fewer drugs?

What are effective methods in educating health care professionals to reduce the stigma that patients living with fibromyalgia experience?

What workplace accommodations can be made to best allow people with fibromyalgia to continue working and manage their disease symptoms throughout the life course?

What factors (e.g. personality, socio-economic status, type of program, type of treatment) affect adherence to treatments for people living with fibromyalgia?

How effective are different medications including drugs given by novel routes of administration (injection, topical, mucosal) in fibromyalgia patients and how do they affect quality of life and ability to work?

What community-based resources would be effective methods of disease management for people with fibromyalgia (e.g. support groups, health literacy coaches)

What are effective methods in educating the public (i.e. family, friends, co-workers, employers to reduce the stigma that patients living with fibromyalgia experience?

Can a treatment algorithm or guidelines recommending the best treatment for symptoms be developed for people living with fibromyalgia?

Can the benefits of medication be maintained after the medication has been withdrawn from the patient’s treatment?

How can people living with fibromyalgia be screened and managed to detect risk for addictions and prevent the development of outcomes such as medication misuse.

Mailing list

Sign up to our newsletter and stay up to date on the latest news from the JLA